Inactive Instrument

Deltagen Inc. Stock Other OTC

Equities

DGEN

US24783R1032

Pharmaceuticals

Sales 2002 17.69M Sales 2003 * - Capitalization 17.48M
Net income 2002 -107M Net income 2003 * - EV / Sales 2002 1.21 x
Net Debt 2002 1.75M Net cash position 2003 * - EV / Sales 2003 * -
P/E ratio 2002
-0.17 x
P/E ratio 2003 *
-
Employees -
Yield 2002 *
-
Yield 2003 *
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 98-12-31
Members of the board TitleAgeSince
Chief Executive Officer - 98-12-31
More insiders
Deltagen, Inc. is a provider of drug discovery tools and services to the biopharmaceutical industry. The Company offers a suite of programs designed to manage the efficiency of drug discovery, including access to biological models, as well as both small-molecule and secreted protein drug targets. In addition, it offers target validation data in the areas of immunology and metabolic diseases. The Company's biology approach is designed to help clear the first and major hurdle of drug target discovery: lead validation. Its DeltaBase is a searchable database of in vivo-derived mammalian gene function information and gene targets. DeltaOne from the Company provides per-gene access to the knockout mice and/or phenotypic data needed.
More about the company